- Home
- PBYI vs RPAY Comparison
PBYI vs RPAY Comparison
Compare PBYI & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | RPAY |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 288.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PBYI | RPAY |
|---|---|---|
| Price | $7.04 | $3.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $7.00 | $6.81 |
| AVG Volume (30 Days) | 411.3K | ★ 669.1K |
| Earning Date | 02-26-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.87 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | $211,995,000.00 | ★ $308,947,000.00 |
| Revenue This Year | N/A | $0.22 |
| Revenue Next Year | N/A | $6.91 |
| P/E Ratio | $9.16 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.58 | $2.98 |
| 52 Week High | $7.21 | $7.84 |
Technical Indicators
Market Signals| Indicator | PBYI | RPAY |
|---|---|---|
| Relative Strength Index (RSI) | 68.59 | 38.93 |
| Support Level | $6.27 | $3.43 |
| Resistance Level | $6.64 | $3.58 |
| Average True Range (ATR) | 0.32 | 0.13 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 89.15 | 15.12 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.